All Stories

  1. Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

    Article • Journal of Central Nervous System Disease, January 2017, SAGE Publications

    Professor Jadwiga Najib

  2. Eszopiclone: Review and Clinical Applications in Chronic and Comorbid Insomnia

    Article • November 2014, Springer Science + Business Media

    Professor Jadwiga Najib

  3. Revising senior pharmacy grand rounds to incorporate longitudinal board review to prepare students for licensing examination

    Article • Currents in Pharmacy Teaching and Learning, May 2013, Elsevier

    Professor Jadwiga Najib

  4. Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder

    Article • Adolescent Health Medicine and Therapeutics, May 2012, Taylor & Francis

    Professor Jadwiga Najib

  5. Efficacy and Safety of Zopiclone and Eszopiclone in the Treatment of Primary and Comorbid Insomnia

    Article • January 2010, Springer Science + Business Media

    Professor Jadwiga Najib

  6. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults

    Article • Clinical Therapeutics, January 2009, Elsevier

    Professor Jadwiga Najib

  7. Eszopiclone

    Article • August 2008, Taylor & Francis

    Professor Jadwiga Najib

  8. Eszopiclone, a Nonbenzodiazepine Sedative-Hypnotic Agent for the Treatment of Transient and Chronic Insomnia

    Article • Clinical Therapeutics, April 2006, Elsevier

    Professor Jadwiga Najib

  9. Fenofibrate in the treatment of dyslipidemia: A review of the data as they relate to the new suprabioavailable tablet formulation

    Article • Clinical Therapeutics, December 2002, Elsevier

    Professor Jadwiga Najib

  10. Entacapone: A catechol-O-methyltransferase inhibitor for the adjunctive treatment of parkinson's disease

    Article • Clinical Therapeutics, June 2001, Elsevier

    Professor Jadwiga Najib

  11. Tardive Dyskinesia

    Article • American Journal of Therapeutics, January 1999, Wolters Kluwer Health

    Professor Jadwiga Najib